AICAR 50mg

AICAR (5-Aminoimidazole-4-carboxamide ribonucleoside/ribonucleotide) is an AMPK activator that mimics the cellular energy depletion signal of exercise without any physical activity. AICAR works by being converted intracellularly to ZMP — a AMP analog that activates AMPK (AMP-Activated Protein Kinase), the master energy sensor of all cells. The result is the same metabolic cascade triggered by sustained aerobic exercise: increased fat oxidation, improved insulin sensitivity, mitochondrial biogenesis, and enhanced endurance capacity.

The "Couch Potato Pill" Studies

AICAR became famous through the work of Ronald Evans at the Salk Institute. In a landmark 2008 Cell Metabolism paper, Evans demonstrated that: - Sedentary mice treated with AICAR for 4 weeks improved endurance capacity by 44% without any exercise - AICAR mice had increased expression of slow-twitch muscle fiber genes and mitochondrial oxidative genes — changes identical to endurance training - When combined with GW501516 (a PPARδ agonist), the combination produced an 80% improvement in endurance

This research established AICAR as a genuine exercise mimetic — not just a metabolic supplement but a compound that triggers the same genetic programs as aerobic training at the molecular level.

AMPK: The Master Energy Sensor

AMPK is activated when the AMP:ATP ratio rises (when cells are low on energy — exactly as in exercise). Once activated, AMPK: - Activates glucose transporters (GLUT-4 translocation) for insulin-independent glucose uptake - Phosphorylates and activates acetyl-CoA carboxylase (ACC) — increasing fat oxidation - Activates PGC-1α — the master regulator of mitochondrial biogenesis - Stimulates GLUT-4 gene expression for lasting insulin sensitivity improvements - Inhibits anabolic pathways (protein synthesis, fatty acid synthesis) that consume energy

AICAR specifically activates AMPK by generating ZMP (which mimics AMP), bypassing the need for actual energy depletion.

Metabolic Benefits

AICAR produces measurable improvements in metabolic health markers: - Reduces fasting glucose in animal models of type 2 diabetes - Improves insulin sensitivity through GLUT-4 upregulation - Reduces hepatic fat accumulation (NAFLD improvement) through hepatic AMPK activation - Reduces visceral fat through enhanced fat oxidation and adipogenesis inhibition - Improves lipid profiles (reduced triglycerides, improved HDL)

Endurance Enhancement Mechanism

AICAR drives a fiber-type shift in skeletal muscle: - Increases expression of slow oxidative (type I) fiber genes: PGC-1α, myoglobin, GLUT-4, HADHA - Increases mitochondrial density in muscle fibers - Enhances oxygen utilization efficiency

These adaptations are what improve endurance capacity — the same molecular changes that occur over months of endurance training can be initiated pharmacologically by AICAR in weeks.

AMPK in Anti-Aging

AMPK is now recognized as one of the most important longevity pathways: - Rapamycin (mTOR inhibitor) extends lifespan in mice — AMPK inhibits mTOR - Metformin (the diabetes drug that may extend healthspan) activates AMPK - Caloric restriction extends lifespan partly through AMPK activation - Exercise extends healthspan partly through AMPK activation AICAR activates this longevity-associated pathway directly, positioning it as relevant beyond athletic performance for healthspan optimization.